ROCHE DIAGNOSTICS POSITIONED TO SERVE PUBLIC HEALTH LABS
HEIGHTENED CONCERNS over bioterrorist attacks have accelerated plans within the public health lab sector to acquire state-of-the art diagnostic technology in DNA typing and enzyme immunoassay.
Roche Diagnostics has instrument systems well-suited for both testing categories. Its DNA analyzers will compete with systems from Applied Biosystems and Cepheid. Major
Subscriber-Only Content. Please Log In.
You are trying to access subscribers-only content. If you are a subscriber, please log in.
If you are not a subscriber, click here to see subscription offers.
Subscribers will have instant access to the Dark Report library, 1997 - the present, giving you the most convenient, accessible archive available in laboratory business intelligence today!
To read our FREE article previews, go to The Dark Report Insider.